Does ANAKINRA Cause Thrombocytosis? 21 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Thrombocytosis have been filed in association with ANAKINRA (Kineret). This represents 0.2% of all adverse event reports for ANAKINRA.
21
Reports of Thrombocytosis with ANAKINRA
0.2%
of all ANAKINRA reports
0
Deaths
12
Hospitalizations
How Dangerous Is Thrombocytosis From ANAKINRA?
Of the 21 reports, 12 (57.1%) required hospitalization.
Is Thrombocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANAKINRA. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does ANAKINRA Cause?
Off label use (4,317)
Drug ineffective (3,368)
Pain (1,344)
Condition aggravated (1,339)
Rheumatoid arthritis (1,300)
Drug intolerance (946)
Joint swelling (921)
Injection site pain (879)
Product dose omission issue (864)
Arthralgia (850)
What Other Drugs Cause Thrombocytosis?
ROMIPLOSTIM (234)
RUXOLITINIB (179)
METHOTREXATE (135)
CLOZAPINE (123)
ADALIMUMAB (94)
GEMCITABINE (71)
PREDNISONE (71)
GEMCITABINE\GEMCITABINE (67)
PACLITAXEL (64)
CARBOPLATIN (63)
Which ANAKINRA Alternatives Have Lower Thrombocytosis Risk?
ANAKINRA vs ANAMORELIN
ANAKINRA vs ANASTROZOLE
ANAKINRA vs ANDEXANET ALFA
ANAKINRA vs ANDROGEL
ANAKINRA vs ANETHOLTRITHION